Opportunity
SAM #75N98026Q00447
NIH Solicitation for Hyperfine Swoop Portable Ultra Low-field MRI System
Buyer
NIH Office of Logistics and Acquisition Operations
Posted
May 29, 2026
Respond By
June 09, 2026
Identifier
75N98026Q00447
NAICS
334510, 339112, 334516
The National Institutes of Health (NIH), Office of Logistics and Acquisition Operations (OLAO), is seeking to acquire advanced neuroimaging technology for research purposes: - Government Buyer: - Department of Health and Human Services (HHS) - National Institutes of Health (NIH) - Office of Logistics and Acquisition Operations (OLAO) - OEM Highlight: - Hyperfine is the specified Original Equipment Manufacturer (OEM) - Product/Service Requested: - Hyperfine Swoop Next-gen Portable Ultra Low-field MRI system - Designed for bedside neuroimaging, especially for critically ill or non-ambulatory patients - No specific part numbers or quantities provided - Unique/Notable Requirements: - System must enable high-quality imaging in locations where traditional MRI is impractical - Supports ongoing neuroimaging research at NIH - Set aside for SBA-eligible vendors - Place of Performance: - NIH facility in Bethesda, Maryland
Description
Requirements
The ultra–low-field portable MRI provides a powerful opportunity to advance our neuroimaging research by enabling high-quality imaging directly at the bedside. Unlike conventional high-field scanners that require specialized infrastructure and patient transport, the Hyperfine Swoop allows us to image critically ill or non-ambulatory patients in their current care environment. This portability greatly expands the patient populations we can study and supports real-time assessment of neurological conditions in settings where traditional MRI is impractical.
Our use of the ultra–low-field system builds on patient studies we initiated several years ago through a strong and ongoing collaboration with Hyperfine. These studies established the feasibility and value of point of care neuroimaging, and the next-generation Swoop now allows us to continue and enhance this work. By pairing ultra–low-field scans with high-field MRI, we can systematically validate low-field metrics against established standards and strengthen the scientific rigor of our research.